To tube or not to tube babies with respiratory distress syndrome

Journal of Perinatology

Volumn 29, Issue , 2009, Pages S68-S72

  Sekar, K C ^a   Corff, K E ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease; Continuous positive airway pressure (CPAP); Premature infant; Respiratory distress syndrome; Surfactant

Indexed keywords

ARTIFICIAL LUNG SURFACTANT;

AGE DISTRIBUTION; ARTIFICIAL VENTILATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONFERENCE PAPER; EXTUBATION; FEASIBILITY STUDY; HUMAN; INTERMETHOD COMPARISON; INTUBATION; LOW BIRTH WEIGHT; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN CARE; NEWBORN MORBIDITY; OUTCOME ASSESSMENT; POSITIVE END EXPIRATORY PRESSURE; PULSE OXIMETRY; RISK ASSESSMENT; TREATMENT INDICATION;

BRONCHOPULMONARY DYSPLASIA; COMBINED MODALITY THERAPY; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE, NEONATAL; INTUBATION, INTRATRACHEAL; PULMONARY SURFACTANTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 65549157921     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2009.28     Document Type: Review

References (40)

1. Stevens TP, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 2004; (3), Art. No.: CD003063. DOI: 10.1002/14651858.CD003063.pub2.
2. Ramanathan R, Sekar K, Soll RF, Wung JT. Expert opinions in managing neonatal respiratory distress syndrome: focus on noninvasive ventilation strategies. {Pamphlet). Publisher: Annenberg Center For Health Sciences at Eisenhower. Available at www.5starmeded.org/shared/4399.pdf(accessed 2006 September 4) 2005.
3. Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 73–81.
4. Van Marter LJ, Allred EN, Pagano M, Sanocka RP, Parad R, Moore M et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? Pediatrics 2000; 105: 1194–1201.
5. Whitehead T, Slutsky AS. The pulmonary physician in critical care-7. Ventilator induced lung injury. Thorax 2002; 57: 635–642.
6. Robinson MJ, Maayan C, Eyal FG, Armon Y, Bar-Yishay E, Godfrey S. Does the pattern of ventilation determine the degree of lung damage following intensive care of the newborn? Isr J Med Sci 1982; 18: 835–839.
7. Speer CP. Inflammation and bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 29–38.
8. Jobe AH, Kramer BW, Moss TJ, Newnham JP, Ikegami M. Decreased indicators of lung injury with continuous positive expiratory pressure in preterm lams. Pediatr Res 2002; 52: 387–392.
9. Latini G, De Felice C, Presta G, Rosati E, Vacca P. Minimal handling and bronchopulmonary dysplasia in extremely low-birth-weight infants. Eur J Pediatr 2003; 162: 227–229.
10. Castillo A, Sola A, Baquero H, Neira F, Alvis R, Deulofeur R et al. Pulse oxygen saturation levels and arterial oxygen tension values in newborns receiving oxygen therapy in the neonatal intensive are unit: Is 85% to 93% an acceptable range? Pediatrics 2008; 121: 882–889.
11. Gal P, Shaffer CL. Acute respiratory distress syndrome In: DiPiro JT, Talbert RL, Yee GC (eds). Pharmacotherapy: A Pathophysiologic Approach. 5th edn. McGraw-Hill: New York, 2002, pp 531–538.
12. Gregory GA, Kitterman JA, Phibbs RH, Tooley WH, Hamilton WK. Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. N Engl J Med 1971; 284: 1333–1340.
13. Dunn PM, Thearle MJ, Parsons AC, Watts JL. Use of the ‘Gregory box’ (CPAP) in treatment of RDS of the newborn: preliminary report. Arch Dis Child 1972; 47: 674–675.
14. Kirby R, Robison E, Schulz J, DeLemos RA. Continuous-flow ventilation as an alternative to assisted or controlled ventilation in infants. Anesth Analg 1972; 51: 871–875.
15. Mulrooney N, Champion Z, Moss TJ, Nitsos I, Ikegami M, Jobe AH. Surfactant and physiologic responses of preterm lambs to continuous positive airway pressure. Am J Respir Crit Care Med 2005; 171: 488–493.
16. Aly HZ. Nasal prongs continuous positive airway pressure: a simple yet powerful tool. Pediatrics 2001; 108: 759–761.
17. DePaoli AG, Davis PG, Faber B, Morley CJ. Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in preterm neonates. Cochrane Database Syst Rev 2002; (4), Art. No.: CD002977.
18. Kahn DJ, Courtney SE, Steele AM, Habib RH. Unpredictability of delivered bubble nasal continuous positive airway pressure; role of bias flow magnitude and nares-prong air leaks. Pediatr Res 2007; 62: 343–347.
19. Polin RA, Sahni R. Continuous positive airway pressure: Old questions and new controversies. J Neonatal Perinat Med 2008; 1: 1–10.
20. Pandit PB, Courtney SE, Pyon KH, Saslow JG, Habib RH. Work of breathing during constant- and variable-flow nasal continuous positive airway pressure in preterm neonates. Pediatrics 2001; 108: 682–685.
21. Blennow M, Jonsson B, Dahlstrom A, Sarman I, Bohlin K, Robertson B. Lung function in premature infants can be improved. Surfactant therapy and CPAP reduce the need of respiratory support. Lakartidningen 1999; 96: 1571–1576.
22. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrom K et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med 1994; 331: 1051–1055.
23. Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B, Bertelsen A et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks’ gestation. Pediatrics 1999; 103: E24.
24. Reininger A, Khala R, Kendig JW, Ryan RM, Stevens TP, Reubens L et al. Surfactant administration by transient intubation in infants 29 to 35 weeks’ gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial. J Perinatol 2005; 25: 703–708.
25. Dani C, Bertini G, Pezzati M, Cecchi A, Caviglioli C, Rubaltelli FF. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants 30 week's gestation. Pediatrics 2004; 113: e560–e563.
26. Haberman B, Shankaran S, Stevenson DK, Papile LA, Stark A, Korones S et al. Does surfactant and immediate extubation to nasal continuous positive airway pressure reduce use of mechanical ventilation? Pediatr Res 2002; 51: 349A.
27. Tooley J, Dyke M. Randomized study of nasal continuous positive airway pressure in the preterm infant with respiratory distress syndrome. Acta Paediatr 2003; 92(10): 1170–1174.
28. Soll RF, Conner JM, Howard D, the Investigators of the Early Surfactant Replacement Study. Early surfactant replacement in spontaneously breathing premature infants with RDS. http://www.pas-meeting.org/2003Seattle/Abstracts/LBFullAbs.htm. PAS 2003: LB12.
29. Texas Neonatal Research Group. Early surfactant for mild to moderate RDS. J Pediatr 1994; 114: 804–808.
30. Sandri F, Ancora G, Lanzoni A, Tagliabue P, Colnaghi M, Ventura ML et al. Prophylactic nasal continuous positive airway pressure in newborns of 28-31 weeks gestation; multicentre randomized controlled clinical trial. Arch Dis Child Fetal Neonatal Ed 2004; 89: 394–398.
31. Stevens TI, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 2007; (2), Art. No.: CD 003063. DOI:10.1002/14651858. CD003063.pub3.
32. Booth C, Premkumar MH, Yannoulis A, Thomson M, Harrison M, Edwards AD. Sustainable use of continuous positive airway pressure in extremely preterm infants during the first week after delivery. Arch Dis Child Fetal Neonatal Ed 2006; 91: 398–402.
33. Ammari A, Suri M, Milisavljevic V, Sahni R, Bateman D, Sanocka U et al. Variables associated with the early failure of nasal CPAP in very low birth weight infants. J Pediatr 2005; 147: 341–347.
34. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA et al. Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia. Pediatrics 2005; 116: 1353–1360.
35. Narendran V, Donovan EF, Hoath SB, Akinbi HT, Steichen JJ, Jobe AH. Early bubble CPAP and outcomes in ELBW preterm infants. J Perinatol 2003; 23: 195–199.
36. Finer NN, Carlo WA, Duara S, Fanaroff AA, Donovan EF, Wright LL et al. Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial. Pediatrics 2004; 114: 651–657.
37. Aly H, Milner JD, Patel K, El-Mohandes AA. Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants? Pediatrics 2004; 114: 697–702.
38. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008; 358(7): 700–708.
39. Adamkin DH. Pragmatic approach to in-hospital nutrition in high-risk neonates. J Perinatol 2005; 25: S7–S11.
40. Sekar KC. The role of continuous positive airway pressure therapy in the management of respiratory distress in extremely premature infants. J Pediatr Pharmacol Ther 2006; 11: 145–152.